Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Weill Medical College of Cornell University
With
This clinical trial is for men and women ages 18 and older with follicular lymphoma with detectable BCL2-t or mantle cell lymphoma with presence of cyclin D1 overexpression (can be newly diagnosed or relapsed). The objective of this study is to assess the possibility of treating follicular lymphoma and mantle cell lymphoma patients with ribavirin and using cell free DNA (cfDNA) for BCL2-t and cyclin D1 extracted from peripheral blood to measure treatment effect. Clinical trials of ribavirin have been conducted in relapsed and refractory acute myeloid leukemia (AML). Ribavirin, an antiviral agent with established doses, has resulted in the regression of the tumor. * Ribavirin 1000 mg will be administered orally twice daily continuously for 28-day cycles. * Patients will be followed for up to 7 months. * Will continue on treatment as long as they are responding to therapy and not experiencing unacceptable side effects.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
